Literature DB >> 15879616

Immunopathogenesis of primary sclerosing cholangitis.

Joy Worthington1, Sue Cullen, Roger Chapman.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology;however, lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for PSC. Associations with inflammatory bowel disease--especially ulcerative colitis--and with other auto-immune diseases, together with genetic associations, further suggest that PSC may be an immune-mediated disease. The immunogenetics of PSC have been the subject of active research, and several human leukocyte antigen (HLA)- and non-HLA-associated genes have been implicated in the development of the disease. Lymphocytes derived from the inflamed gut may enter the liver via the enterohepatic circulation to cause hepatic disease.PSC may be triggered in genetically susceptible individuals by infections or toxins entering the portal circulation through a permeable colon and, therefore, evoking an abnormal immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879616     DOI: 10.1385/CRIAI:28:2:093

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  82 in total

1.  Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; G K Sachdev; A Heryet; P M Kelly; K A Fleming; D P Jewell
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

2.  HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

Authors:  W Z Mehal; Y M Lo; B P Wordsworth; J M Neuberger; S C Hubscher; K A Fleming; R W Chapman
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

3.  Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.

Authors:  K Hata; D H Van Thiel; R B Herberman; T L Whiteside
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

Review 4.  Gamma delta cells regulate autoimmunity.

Authors:  A Hayday; L Geng
Journal:  Curr Opin Immunol       Date:  1997-12       Impact factor: 7.486

5.  MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).

Authors:  A J Grant; P F Lalor; S G Hübscher; M Briskin; D H Adams
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

6.  Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.

Authors:  H Yang; D K Vora; S R Targan; H Toyoda; A L Beaudet; J I Rotter
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

Authors:  R W Chapman; M Cottone; W S Selby; H A Shepherd; S Sherlock; D P Jewell
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

8.  Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.

Authors:  Xuesong Yang; Susan N Cullen; Jin H Li; Roger W Chapman; Derek P Jewell
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

9.  Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S Bloom; K Fleming; R Chapman
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 2.  TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?

Authors:  Verena Keitel; Maria Reich; Dieter Häussinger
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

4.  Perinatal events and the risk of developing primary sclerosing cholangitis.

Authors:  Annika Bergquist; Scott M Montgomery; Ulrika Lund; Anders Ekbom; Rolf Olsson; Stefan Lindgren; Hanne Prytz; Rolf Hultcrantz; Ulrika Broomé
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 5.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 6.  Current research on the treatment of primary sclerosing cholangitis.

Authors:  Ahmad H Ali; Elizabeth J Carey; Keith D Lindor
Journal:  Intractable Rare Dis Res       Date:  2015-02

7.  Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.

Authors:  J Anthony Brandon; Jacqueline Perez; C Darrell Jennings; Donald A Cohen; V J Sindhava; S Bondada; Alan M Kaplan; J Scott Bryson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

Review 8.  Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?

Authors:  Ulrich Beuers; Gerd A Kullak-Ublick; Thomas Pusl; Erik R Rauws; Christian Rust
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 9.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

10.  Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.

Authors:  Christian Rupp; Alexander Rössler; Taotao Zhou; Conrad Rauber; Kilian Friedrich; Andreas Wannhoff; Karl-Heinz Weiss; Peter Sauer; Peter Schirmacher; Caner Süsal; Wolfgang Stremmel; Daniel N Gotthardt
Journal:  United European Gastroenterol J       Date:  2017-06-17       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.